Skip to content

Gabapentin in bipolar disorder

Gabapentin as a combination treatment with lithium in adolescents with bipolar disorder: a double- blind, randomized, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201010172000N4
Enrollment
31
Registered
2010-10-20
Start date
2007-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bipolar disorder. Bipolar affective disorder

Interventions

Intervention 1: Intervention: lithium at doses producing a serum concentration of 0.8-1 meq/l + GBP with a target daily dose of 400mg/day. Intervention 2: Control: lithium at doses producing a serum c
Treatment - Drugs
Intervention: lithium at doses producing a serum concentration of 0.8-1 meq/l + GBP with a target daily dose of 400mg/day
Control: lithium at doses producing a serum concentration of 0.8-1 meq/l + placebo

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1)10 -17 years of age 2) score more than 20 in Young Mania Rating Scale (YMRS, Yongstorm , et al, 2003) 3)not being on any psychiatric medication for at least two weeks prior to entry into this trial 4) signing a written informed consent. Exclusion criteria: 1) any significant medical illness, 2) IQ lower than70, 3) meeting criteria for substance dependence and abuse in the month before trial

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mania severity. Timepoint: before intervention and every two weeks. Method of measurement: Young Mania ratin Scale.

Secondary

MeasureTime frame
Anxiety severity. Timepoint: before intervention and every two weeks. Method of measurement: Hamilton rating scale.;Depression severity. Timepoint: before intervention and every two weeks. Method of measurement: Beck Depression Inventory.;Side effects. Timepoint: on weeks 2,4,6,8. Method of measurement: side effects checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRozita Davari-Ashtiani

Shahid Beheshti University of Medical sciences

rodavari@sbmu.ac.ir+98 21 7755 1023

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026